MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    The Association between Non-Motor Symptom Burden and Quality of Life in the Nigeria Parkinson Disease Research Network Registry

    O. Odeniyi, O. Ojo, O. Agabi, N. Okubadejo, NPD. Research Network (Lagos, Nigeria)

    Objective: To determine the relationship between non-motor symptom (NMS) burden and quality of life in persons living with Parkinson’s disease (PD) recruited into the registry.…
  • 2024 International Congress

    Comparison of Motor, Non-motor, Social Aspects between Men with Parkinson’s Disease with and without Erectile Dysfunction

    K. Nobrega, B. Souza, B. Alexandre, M. Silva, A. Frazao, A. Roque, I. Nascimento, ME. Piemonte (Sao Paulo, Brazil)

    Objective: This study aimed to compare motor, non-motor, and social aspects of men with PD who have and do not have ED. Background: Sexual dysfunction…
  • 2024 International Congress

    Deep learning-based Prediction of Visual Dysfunction in Parkinson’s Disease from 31 Brain Regions of Interest using Quantitative Diffusion MRI

    C. Raimondo, L. Singanamala, M. Alizadeh (Philadelphia, USA)

    Objective: Compare the performance of deep learning and machine learning models trained on quantitative diffusion measurements in the prediction of visual dysfunction in Parkinson’s Disease…
  • 2024 International Congress

    Exploring the Influence of Sleep Disorders on Speech Intensity in Individual’s with Parkinson’s Disease

    A. Senthinathan, K. Bean (Buffalo, USA)

    Objective: This study aimed to examine the impact that sleep disorders and disturbances have on speech intensity in individuals with Parkinson’s disease (PD). Background: PD…
  • 2024 International Congress

    Listening to the Insight: The Underdiagnosis of Depression in People Living with Parkinson’s Disease

    G. Rivera-Monroy, RJ. Baños-Betancourt, K. Velázquez-Román, CF. álvarez-Hernández, AL. Guerra-Anzaldo, WF. Moguel-Cardín, A. Domínguez-García, MF. Medina-Pérez, JC. Delgado-Uriarte, NP. Moreno-Aldama, A. Uribe-León, MC. Unda-Mcfarlane, AJ. Hernández-Medrano, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To determine the prevalence of risk of undiagnosed depression among people living with Parkinson's disease (PwP) without a prior depression diagnosis. Background: Parkinson's disease…
  • 2024 International Congress

    Creating a Multi-institutional, Interdisciplinary Functional Neurological Disorder (FND) Clinic in an Urban Setting

    D. Kipnis, Z. Grin, S. Leung, Z. L'Erario, C. Amlang (New York, USA)

    Objective: To describe the process to create an interdisciplinary FND clinic with independent practitioners in the New York City area. Background: Estimated 9,000 people in…
  • 2024 International Congress

    Quantitative EEG Analysis for Comparing Drug-Induced Parkinsonism and Parkinson’s Disease

    S. Seo, S. Kim, SP. Kim, J. Kim, D. Chung, SY. Kang (Ulsan, Republic of Korea)

    Objective: To know whether EEG could be a neural indicator that distinguish between Drug-induced parkinsonism (DIP) and Parkinson’s disease (PD). Background: DIP is the second…
  • 2024 International Congress

    Characteristics of Parkinson’s disease and associated healthcare resource utilization trends in a US all-payer health administrative claims database

    W. Zhang, S. Shuvo, A. Gabriel, A. Yaldo, G. Agreda, C. Goetzsche, T. Machewitz, M. Nadimi, J. Lott (Whippany, USA)

    Objective: To describe sociodemographic characteristics and healthcare resource utilization (HRU) among Parkinson’s disease (PD) patients across US health insurance plans. Background: PD affects nearly 1…
  • 2024 International Congress

    Parkinson’s disease in Brazil: prevalence and patient characteristics in a nationwide representative population-based cohort.

    D. Teixeira-Dos-Santos, G. Magalhães Pereira, G. Alves Marconi, T. Hugentobler Schlickmann, AF. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: To assess the prevalence, sociodemographic, and clinical characteristics of Parkinson’s disease (PD) among Brazilian older adults in a large nationwide representative cohort. Background: The…
  • 2024 International Congress

    Clinical profile of early-onset Parkinson’s disease

    S. Peña Martinez, R. Ayala Minero, R. Amaya, A. Medina Escobar, P. Salles (San Salvador, El Salvador)

    Objective: Describe motor and non-motor symptoms, complications and treatment in patients with early-onset Parkinson's disease (EOPD) Background: PD usually affecting people over age 60, clinically…
  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley